Skip to main content

Acne News (Page 2)

Related terms: Acne Vulgaris, Blackheads, Cystic acne, Pimples, Whiteheads, Zits, Breakouts

FDA Approves Twyneo (tretinoin and benzoyl peroxide) for the Treatment of Acne Vulgaris

NESS ZIONA, Israel, July 27, 2021 (GLOBE NEWSWIRE) – Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing and commercializing branded and generic...

FDA Approves Winlevi (clascoterone) Cream for the Treatment of Acne

Lainate, Italy – August 27, 2020 – Cassiopea SpA (SIX: SKIN), today announced that the United States Food and Drug Administration (FDA) approved Winlevi (clascoterone cream 1%) for the treatment of ac...

FDA Approves Arazlo (tazarotene) Lotion for the Topical Treatment of Acne Vulgaris

BRIDGEWATER, N.J., Dec. 19, 2019 /PRNewswire/ – Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health...

FDA Approves Amzeeq (minocycline) Topical Foam for the Treatment of Moderate to Severe Acne

REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) – Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced tha...

FDA Approves Aklief (trifarotene) Cream, a New Topical Retinoid for the Treatment of Acne

FORT WORTH, Texas (October 4, 2019) Galderma, a global leader focused on meeting the world's increasing skin health needs, announced today that the U.S. Food and Drug Administration (FDA) approved...

FDA Approves Seysara (sarecycline) for the Treatment of Moderate to Severe Acne

Barcelona - 2nd October 2018 – Almirall, S.A. announced today that the Food and Drug Administration (FDA) has approved Seysara (sarecycline), a new, innovative first in class tetracycline-derived...

FDA Approves Seysara (sarecycline) for the Treatment of Moderate to Severe Acne

Barcelona - 2nd October 2018 – Almirall, S.A. announced today that the Food and Drug Administration (FDA) has approved Seysara (sarecycline), a new, innovative first in class tetracycline-derived...

Ortho Dermatologics Receives FDA Approval for Altreno (tretinoin 0.05%) Lotion For Acne

LAVAL, Quebec, Aug. 24, 2018 /PRNewswire/ – Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world and a division of Bausch Health Companies Inc....

FDA Approves Differin Gel 0.1% for Over-the-Counter Use to Treat Acne

July 8, 2016 – The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is...

Allergan Announces FDA Approval of Aczone (dapsone) Gel, 7.5% for Treatment of Acne Vulgaris

DUBLIN, Feb. 25, 2016 /PRNewswire/ – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug...

Galderma Receives FDA Approval for Epiduo Forte (adapalene and benzoyl peroxide) for Acne

FT. WORTH, Texas – July 16, 2015 -Galderma Laboratories, L.P. announced today that the U.S. Food and Drug Administration (FDA) approved antibiotic-free Epiduo Forte (adapalene and benzoyl peroxide) G...

Bellafill Receives FDA Approval for the Treatment of Acne Scars

San Diego, CA, Jan. 6, 2015 - Suneva Medical, Inc., a privately-held aesthetics company, announced today that the U.S. Food and Drug Administration (FDA) has approved the dermal filler, Bellafill,...

Valeant Pharmaceuticals Announces FDA Approval of Onexton Gel for Acne Vulgaris

LAVAL, Quebec, Nov. 25, 2014 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. announced today that it has received approval from the Food and Drug Administration (FDA) for Onexton Gel...

Aqua Pharmaceuticals Announces FDA Approval of Acticlate (doxycycline hyclate USP) Tablets

West Chester, Pa. — July 28, 2014 West Chester-based Aqua Pharmaceuticals, an Almirall company, today announces the U.S. Food and Drug Administration (FDA) approval of the NDA for Acticlate (...

FDA Medwatch Alert: Over-The-Counter Topical Acne Products: Drug Safety Communication - Rare But Serious Hypersensitivity Reactions

Sold under various brand names such as Proactiv, Neutrogena, MaxClarity, Oxy, Ambi, Aveeno, Clean & Clear, and as store brands. [Posted 06/25/2014] ISSUE: FDA is warning that certain...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Rosacea, Dermatological Disorders

Related drug support groups

doxycycline, cephalexin, spironolactone, Keflex, Accutane, sulfur, sulfamethoxazole / trimethoprim, Yasmin, Milk of Magnesia, isotretinoin, tetracycline, Retin-A